CAVA results for the fourth quarter of 2025

diggingThe Mediterranean fast-casual restaurant chain on Tuesday reported record revenue for fiscal 2025 and forecast sales growth for fiscal 2026.…

What's next for Novo Nordisk's anti-obesity drug CagriSema?

A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…

Eli Lilly launches anti-obesity drug Zepbound with one-month dosage

An Eli Lilly & Co. Zepbound injection pen placed in the Brooklyn borough of New York on March 28, 2024.…